Previous Close | 21.55 |
Open | 21.50 |
Bid | 21.36 x 0 |
Ask | 21.53 x 0 |
Day's Range | 21.50 - 21.53 |
52 Week Range | 15.21 - 21.60 |
Volume | |
Avg. Volume | 4,287 |
Market Cap | 61.461B |
Beta (5Y Monthly) | 1.10 |
PE Ratio (TTM) | 4.62 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.92 (4.26%) |
Ex-Dividend Date | May 21, 2024 |
1y Target Est | N/A |
John Hancock, along with its Toronto-based parent company Manulife (NYSE: MFC), today announced a five-year, multimillion-dollar research collaboration with the Massachusetts Institute of Technology (MIT) AgeLab, a multi-disciplinary research institute that works with business, government, and NGOs, leading innovation and research to help improve the quality of life for the aging population and their loved ones. Over the next five years, Manulife/John Hancock and the MIT AgeLab will collaborate
Manulife Investment Management (Manulife IM) announced today that it has launched two new liquid alternative funds: Manulife Alternative Opportunities Fund and Manulife Strategic Income Plus Fund. The funds are managed by Manulife Investment Management's Canadian fixed-income team and global multi-sector fixed-income team, respectively. The teams manage more than CAD$54 billion combined in assets globally.1
Manulife Financial Corporation (Manulife) announced today that each of the following 13 nominees proposed to be elected at the Annual Meeting of Shareholders held earlier today has been elected. The detailed results of the vote for the election of directors are set out below.